Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:46:21.053Z.
Calculation as of: 2026-10-06T14:46:21.053Z.
Quote observation: 2026-10-06T14:43:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1719e487edf1987d8b1f0a43ac2cfa0d2aa61af237e007c9f807b404ec58ada8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-02-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Citius Pharmaceuticals, Inc.
Market Cap
$13.99M
EV/EBITDA Ratio
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO |
|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | $13.99M | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.93M | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.44M | N/A |
| IN8bio, Inc. (INAB)vs › | $13.47M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.69M | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.44M | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2015-02-17 | 117.63x |
| 2015-02-13 | 117.63x |
| 2015-02-12 | 117.57x |
| 2015-02-11 | 120.79x |
| 2015-02-10 | 127.31x |
| 2015-02-09 | 127.24x |
| 2015-02-06 | 111.13x |
| 2015-02-05 | 131.54x |
| 2015-02-04 | 131.54x |
| 2015-02-03 | 131.61x |
| 2015-02-02 | 131.54x |
| 2015-01-30 | 116.56x |
| 2015-01-29 | 116.50x |
| 2015-01-28 | 104.74x |
| 2015-01-27 | 104.68x |
| 2015-01-26 | 111.13x |
| 2015-01-23 | 111.13x |
| 2015-01-22 | 104.68x |
| 2015-01-21 | 115.42x |
| 2015-01-20 | 120.79x |
| 2015-01-16 | 120.79x |
| 2015-01-15 | 120.86x |
| 2015-01-14 | 120.79x |
| 2015-01-13 | 120.79x |
| 2015-01-12 | 120.79x |
| 2015-01-09 | 120.79x |
| 2015-01-08 | 119.72x |
| 2015-01-07 | 119.72x |
| 2015-01-06 | 115.42x |
| 2015-01-05 | 115.42x |
| 2015-01-02 | 109.03x |
| 2014-12-31 | 109.03x |
| 2014-12-30 | 109.03x |
| 2014-12-29 | 108.98x |
| 2014-12-26 | 110.05x |
| 2014-12-24 | 110.11x |
| 2014-12-23 | 110.11x |
| 2014-12-22 | 110.05x |
| 2014-12-19 | 110.05x |
| 2014-12-18 | 110.05x |
| 2014-12-17 | 129.39x |
| 2014-12-16 | 131.61x |
| 2014-12-15 | 131.61x |
| 2014-12-12 | 131.61x |
| 2014-12-11 | 131.61x |
| 2014-12-10 | 131.61x |
| 2014-12-09 | 131.61x |
| 2014-12-08 | 131.61x |
| 2014-12-05 | 131.61x |
| 2014-12-04 | 131.61x |
| 2014-12-03 | 131.61x |
| 2014-12-02 | 131.61x |
| 2014-12-01 | 129.39x |
| 2014-11-28 | 131.61x |
| 2014-11-26 | 131.61x |
| 2014-11-25 | 131.61x |
| 2014-11-24 | 131.61x |
| 2014-11-21 | 131.61x |
| 2014-11-20 | 131.61x |
| 2014-11-19 | 131.61x |
| 2014-11-18 | 131.61x |
| 2014-11-17 | 131.54x |
| 2014-11-14 | 104.74x |
| 2014-11-13 | 104.74x |
| 2014-11-12 | 104.74x |
| 2014-11-11 | 104.74x |
| 2014-11-10 | 104.74x |
| 2014-11-07 | 104.74x |
| 2014-11-06 | 104.74x |
| 2014-11-05 | 104.74x |
| 2014-11-04 | 104.74x |
| 2014-11-03 | 104.74x |
| 2014-10-31 | 104.74x |
| 2014-10-30 | 104.74x |
| 2014-10-29 | 104.74x |
| 2014-10-28 | 104.74x |
| 2014-10-27 | 104.74x |
| 2014-10-24 | 104.74x |
| 2014-10-23 | 104.74x |
| 2014-10-22 | 104.74x |
| 2014-10-21 | 104.74x |
| 2014-10-20 | 104.74x |
| 2014-10-17 | 104.74x |
| 2014-10-16 | 104.74x |
| 2014-10-15 | 104.74x |
| 2014-10-14 | 104.74x |
| 2014-10-13 | 104.74x |
| 2014-10-10 | 104.74x |
| 2014-10-09 | 104.74x |
| 2014-10-08 | 104.74x |
| 2014-10-07 | 104.74x |
| 2014-10-06 | 104.74x |
| 2014-10-03 | 104.74x |
| 2014-10-02 | 104.68x |
